Myomo Company Leadership
MYO Stock | USD 5.48 0.14 2.49% |
Myomo employs about 101 people. The company is managed by 10 executives with a total tenure of roughly 5 years, averaging almost 0.0 years of service per executive, having 10.1 employees per reported executive. Analysis of Myomo's management performance can provide insight into the firm performance.
Paul Gudonis CEO Chief Executive Officer, Director |
Steve Kelly Chairman Founder, Chairman of the Board, President and Chief Operating Officer |
Myomo |
Myomo's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Myomo's future performance. Based on our forecasts, it is anticipated that Myomo will maintain a workforce of about 100 employees by January 2025.Myomo Management Team Effectiveness
The company has Return on Asset of (0.3145) % which means that on every $100 spent on assets, it lost $0.3145. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8254) %, meaning that it generated no profit with money invested by stockholders. Myomo's management efficiency ratios could be used to measure how well Myomo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of December 2024, Return On Tangible Assets is likely to drop to -0.59. In addition to that, Return On Capital Employed is likely to drop to -0.95. At this time, Myomo's Net Tangible Assets are very stable compared to the past year. As of the 3rd of December 2024, Non Currrent Assets Other is likely to grow to about 97 K, while Total Assets are likely to drop about 10.4 M.As of the 3rd of December 2024, Common Stock Shares Outstanding is likely to grow to about 31 M, while Net Loss is likely to drop (10.1 M).
Myomo Workforce Comparison
Myomo Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,340. Myomo holds roughly 101 in number of employees claiming about 8% of equities under Health Care industry.
Myomo Profit Margins
The company has Net Profit Margin of (0.33) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.1) %, which entails that for every $100 of revenue, it lost $0.1.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.77 | 0.6851 |
|
|
Myomo Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Myomo insiders, such as employees or executives, is commonly permitted as long as it does not rely on Myomo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Myomo insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-06-01 | 1.7143 | 12 | 7 | 425,354 | 58,643 |
2024-03-01 | 0.3333 | 2 | 6 | 75,000 | 20,161 |
2023-12-01 | 0.1667 | 1 | 6 | 50,000 | 38,670 |
2023-09-01 | 4.5 | 9 | 2 | 243,007 | 250.00 |
2023-06-01 | 1.6 | 8 | 5 | 779,952 | 5,989 |
2023-03-01 | 2.3333 | 7 | 3 | 467,999 | 401.00 |
2022-12-01 | 0.6 | 3 | 5 | 9,666 | 1,045 |
2022-06-01 | 0.6154 | 8 | 13 | 203,510 | 26,297 |
2022-03-01 | 0.6667 | 2 | 3 | 10,000 | 388.00 |
2021-12-01 | 1.3333 | 4 | 3 | 2,419 | 1,961 |
2021-06-01 | 1.625 | 13 | 8 | 131,599 | 9,545 |
2019-12-01 | 2.0 | 2 | 1 | 41,333 | 25,006 |
2019-06-01 | 8.0 | 8 | 1 | 313,364 | 802.00 |
2019-03-01 | 1.125 | 9 | 8 | 186,928 | 38,875 |
2018-03-01 | 1.5 | 18 | 12 | 283,445 | 30,594 |
2017-09-01 | 0.4 | 2 | 5 | 35,000 | 33,577 |
2017-06-01 | 0.2857 | 14 | 49 | 569,718 | 1,328,565 |
Myomo Notable Stakeholders
A Myomo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Myomo often face trade-offs trying to please all of them. Myomo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Myomo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Paul Gudonis | Chief Executive Officer, Director | Profile | |
Steve Kelly | Founder, Chairman of the Board, President and Chief Operating Officer | Profile | |
David Henry | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Profile | |
Joseph Chicoskie | Director Marketing | Profile | |
Fredrick Nahm | Medical Director | Profile | |
Harry MD | Chief Officer | Profile | |
Colin Anderson | Global Operations | Profile | |
Galina Shtivelman | Senior Resources | Profile | |
Micah Mitchell | Chief Officer | Profile | |
Jonathan Naft | General Manager - O&P | Profile |
About Myomo Management Performance
The success or failure of an entity such as Myomo Inc often depends on how effective the management is. Myomo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Myomo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Myomo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.56) | (0.59) | |
Return On Capital Employed | (0.90) | (0.95) | |
Return On Assets | (0.56) | (0.59) | |
Return On Equity | (0.91) | (0.95) |
Myomo Workforce Analysis
Traditionally, organizations such as Myomo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Myomo within its industry.Myomo Manpower Efficiency
Return on Myomo Manpower
Revenue Per Employee | 190.5K | |
Revenue Per Executive | 1.9M | |
Net Loss Per Employee | 80.7K | |
Net Loss Per Executive | 814.8K | |
Working Capital Per Employee | 80.9K | |
Working Capital Per Executive | 817.4K |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.835 | Quarterly Revenue Growth 0.813 | Return On Assets (0.31) | Return On Equity (0.83) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.